Jennifer L Taubert Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 month, 2 weeks ago
Jennifer L Taubert has an estimated net worth of at least $49.5 million*, as of Feb. 19, 2025. They own shares of JNJ stock. They have sold 136,320 shares of JNJ stock since 2021, for an estimated $22.9 million.
Jennifer L Taubert $JNJ SEC Form 4 Insider Trading
Jennifer L Taubert has filed a total of 2 insider trades in $JNJ since 2021. Their most recent trade was a sale of 59,397 shares, made on Feb 09, 2024. Their largest trade was a sale of 76,923 shares, made on Nov 22, 2022. We estimate that they now own shares of $JNJ, worth an estimated $26.6 million.
Insider Trading at $JNJ
There have been a total of 350 insider trades reported at $JNJ since 2021, with 1,000 shares purchased and 657,475 shares sold. The most active insider traders in $JNJ stock have been Peter Fasolo, Thibaut Mongon, and William Hait. The most recent trade was a sale of 6,999 shares reported by Robert J Decker (VP Corporate Controller), made on Feb 25, 2025.
History of Insider Stock Trades by Jennifer L Taubert
$JNJ Executives and Stock Owners with Insider Trades
-
Peter Fasolo, Exec VP, Chief HR Officer
-
Thibaut Mongon, Exec VP, WW Chair, Consumer
-
William Hait, See Remarks
-
Kathryn E Wengel, EVP, Chief GSC Officer
-
Joseph J Wolk, Exec VP, CFO
-
Robert J Decker, Controller, CAO
-
Ashley Mcevoy, EVP, WW Chair, MedTech
-
Jennifer L Taubert, EVP, WW Chair, Pharmaceuticals
-
Robert J Decker, VP Corporate Controller
-
James D. Swanson, See Remarks
-
Kathryn E Wengel, EVP, Chief TO and Risk Officer
-
Timothy Schmid, EVP, WW Chair, MedTech
-
Vanessa Broadhurst, EVP, Global Corp Affairs
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.